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Abstract
Background:  Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus with a Worldwide
distribution in cattle and is often isolated from the uterus of animals with postpartum metritis or
pelvic inflammatory disease. Virus strain adaptation to an organ, tissue or cell type is an important
issue for the pathogenesis of disease. To explore the mechanistic role of viral strain variation for
uterine disease, the present study aimed to develop a tool enabling precise genetic discrimination
between strains of BoHV-4 and to easily manipulate the viral genome.
Methods: A strain of BoHV-4 was isolated from the uterus of a persistently infected cow and
designated BoHV-4-U. The authenticity of the isolate was confirmed by RFLP-PCR and sequencing
using the TK and IE2 loci as genetic marker regions for the BoHV-4 genome. The isolated genome
was cloned as a Bacterial Artificial Chromosome (BAC) and manipulated through recombineering
technology
Results: The BoHV-4-U genome was successfully cloned as a BAC, and the stability of the pBAC-
BoHV-4-U clone was confirmed over twenty passages, with viral growth similar to the wild type
virus. The feasibility of using BoHV-4-U for mutagenesis was demonstrated using the BAC
recombineering system.
Conclusion: The analysis of genome strain variation is a key method for investigating genes
associated with disease. A resource for dissection of the interactions between BoHV-4 and host
endometrial cells was generated by cloning the genome of BoHV-4 as a BAC.
Background
Uterine infections are important because they disrupt not
only the function of the uterus, but also the ovary and the
overarching higher control centres in the hypothalamus
and pituitary [1]. The inflammatory and immune
response to uterine infection compromises animal welfare
as well as affecting fertility. Indeed, uterine disease causes
infertility during infection and sub-fertility even after suc-
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cessful resolution of the disease. Understanding the mech-
anisms underlying the effect of microbial infection and
the associated immune response on bovine reproduction
is important to develop new treatments and disease pre-
vention strategies [2].
Postpartum metritis or pelvic inflammatory disease affects
up to 40% of dairy cattle [1]. It is assumed that most uter-
ine disease is of bacterial origin. Virus isolation or serol-
ogy is rarely considered even though abortion may follow
infection with a variety of alpha-, beta- and gammaher-
pesvirus. Bovine herpesvirus 4 (BoHV-4) is a virus consist-
ently associated with cases of bovine metritis. The first
reported isolation of BoHV-4 from a case of bovine metri-
tis was in 1973 [3]. Later several other isolates were
obtained from cows with reproductive disorders from sev-
eral countries, including Italy [4] and India [5]. In Bel-
gium, BoHV-4 seroprevalence was associated with
postpartum metritis, and chronic infertility of cattle [6].
Postpartum metritis has also been associated with BoHV-
4 in the USA [7,8], Spain [9] and Serbia [10].
BoHV-4 is tropic for endometrial stromal and epithelial
cells, leading to non-apoptotic cell death and de novo viral
production associated with increased stromal cell prostag-
landin-endoperoxide synthase 2 (PTGS2) protein and
prostaglandin E2 (PGE) secretion [11,12]. The successfull
replication of BoHV-4 in bovine endometrial cells was
attribuited to post-entry events, with rapid viral reconsti-
tution following the electroporation of nude viral DNA
into endometrial stromal and epithelial cells [11,12]. A
plausible mechanism underling this rapid activation of
BoHV-4 replication in the endometrium is the capability
of endometrial cells to transactivate the BoHV-4 Immedi-
ate Early 2 (IE2) gene promoter [11]. The IE2 gene is the
molecular master swich for herpesvirus replication [13].
Furthermore, extracellular stimuli associated with the
intrauterine microenvironment such as E. coli LPS and
PGE transactivated the BoHV-4 IE2 gene promoter and
viral replication [11]. BoHV-4 replication was also reacti-
vated in latently infected macrophages when cocultured
with endometrial stromal cells [11,12]. Thus, a model for
endometrial BoHV-4 disease was proposed [1], involving
a vicious circle comprising of bacterial endometritis lead-
ing to secretion of PGE, then PGE and LPS stimulating
viral replication, which causes further endometrial tissue
damage and inflammation.
Although BoHV-4 has been isolated from different lesions
and from healthy animals, the relationship between bio-
types of BoHV-4 and uterine disease has not been
explored. The present study aimed to develop a tool ena-
bling precise genetic discrimination between strains of
BoHV-4 and to easily manipulate the viral genome.
BoHV-4 was isolated from a cow affected with non-
responsive post-partum metritis, characterized and the
genome cloned as a bacterial artificial chromosome
(BAC). This new uterine BAC-BoHV-4 clone represents a
resource for functional genomic studies of BoHV-4 genes
adapted to the endometrium, and will lead to new
insights into the relationship between BoHV-4 and post-
partum metritis.
Methods
Herd screening and isolation of BoHV-4
A dairy herd comprising of 73 cows that had a high inci-
dence of postpartum metritis, abortion, and infertility was
screened by indirect fluorescent antibody test (IFAT) for
BoHV-4 antibodies. Briefly, IFAT was performed as fol-
low: BoHV-4 infected and uninfected BEK cells were
seeded onto 18-well glass slides, fixed in cold acetone and
stored at -20°C until used. Sera were serially diluted in
phosphate buffered saline (PBS) and 30 μl/well added to
the infected and uninfected cells. For each slide, negative
and positive control sera were used, as well as control
wells containing BoHV-4 infected or uninfected cells
treated only with the secondary antibody. After 1 h incu-
bation at 37°C, the slides were washed three times in PBS
and incubated for 1 h at 37°C with fluorescein isothiocy-
anate conjugated anti-bovine immunoglobulin G. At the
same time, cells were counterstained with Evans Blue Dye
(EBD; Sigma). Fluorescence was detected using a Zeiss
Axiovert epifluorescent microscope and images acquired
with the Axiocam Zeiss system. Sera were considered pos-
itive for BoHV-4 antibody when green fluorescence was
detected at a dilution ≥ 1:40, with no fluorescence for
uninfected cells at 1: 20.
Endometrial cells collection by uterine trypsin flushing
A Holstein Friesian cow with a history of metritis was
identified by IFAT as persistently infected with BoHV-4.
The cow was 4 years old with a body condition score of 3
(scale 1 to 5), with no pyrexia or other clinical signs of dis-
ease. The cow was treated with a prostaglandin F2α ana-
logue (Striate, Schering-Plough, Milano, Italy) to induce
estrus 4 days later when endometrial cells were collected
by flushing the uterus. Briefly, a Foley catheter was intro-
duced through the cervix into the uterine lumen guided by
rectal palpation and 50 ml of a trypsin EDTA solution
(0,25% trypsin, 1 mM EDTA in PBS) infused into the
lumen and the uterus gently massaged for 2 min before
aspiration into a 50 ml tube. After collection, 5 ml FBS
was added to the suspension and the endometrial cells
were collected by centrifugation at 500 × g for 5 min. The
cells were washed twice with 10 ml medium comprising
of Dulbecco's modified essential medium (D-MEM;
Sigma), 10% FBS (Sigma), 50 IU/ml penicillin (Sigma),
50 μg/ml streptomycin (Sigma) and 2.5 μg/ml Amphoter-
icin B (Sigma), and then re-suspended in 2 ml of medium
and stored at -80°C.Reproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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BoHV-4-U isolation
The following BoHV-4-sensitive cell lines were obtained:
bovine arterial endothelial (BAE-7372) from S. Grolli
(Veterinary Biochemistry Institute, Parma University,
Italy); Madin Derby Bovine Kidney (MDBK CCL-22) from
ATCC (ATCC American Type Culture Collection, Manas-
sas, USA); and bovine embryo kidney (BEK) and bovine
embryo lung (BEL) cells from M. Ferrari (Istituto Zoopro-
filattico Sperimentale, Brescia, Italy). All cells were cul-
tured in D-MEM (Sigma) containing 10% FBS (Sigma), 2
mM of L-glutamine (Sigma), 100 IU/ml of penicillin
(Sigma), 100 μg/ml of streptomycin (Sigma) and 2.5 μg/
ml of Amphotericin B (Sigma). The uterine endometrial
cells were co-cultured with BAE-7372, MDBK, BEL and
BEK cells in culture flasks until plaques characteristic of a
cytopathic effect (CPE) developed. Single plaques were
purified using 0.2% agarose (Sigma) gel three times.
Flasks containing plaques were frozen in liquid nitrogen
and thawed, the medium containing cell plaques centri-
fuged at 500 × g and the supernatant filtered through a 0.2
μm syringe filter (Minisart, Sartorius) and stored at -80°C.
BoHV-4-U plaque immuno-peroxidase staining
The cell plaques were washed three times with PBS
(Sigma) and fixed in 4% paraformaldehyde (Sigma) for
10 min at 37°C. The cells were washed twice and incu-
bated for 5 min with PBS, 0.1% BSA at 20°C, and then
incubated for a further 5 min with PBS, 0.3% Triton X-100
(Sigma). The cells were then washed three times with PBS,
and incubated for 10 min at 37°C with 0.15% hydrogen
peroxide (Sigma) in PBS. Rabbit anti-BoHV-4 hyperim-
mune serum, diluted 1:500 in PBS, was then added to the
cells for 2 h at 37°C. After three washes with PBS, the cells
were incubated with peroxidase-conjugated secondary
antibody (Sigma), diluted 1:500 in PBS, for 1 h at 37°C,
and washed three times with PBS. Secondary antibody
was detected by development in 250 μg/ml DAB (Sigma),
0.015% H2O2, 50 mM Tris pH 7.4, for 10 min at 20°C.
BoHV-4-U characterization
Viral infected cells were lysed overnight in TEL (10 mM
Tris-HCl, pH 7.5, 1 mM EDTA) buffer containing 0.5%
sodium dodecyl sulfate (SDS) (Sigma) and 100 μg/ml of
proteinase K (Sigma) at 37°C. Nucleic acids were
extracted by treatment with phenol-chloroform and pre-
cipitated with ethanol. Treatment with 100 μg/ml of
RNAse A (Sigma) was performed for 1 h, after which the
DNA was extracted with phenol and precipitated with eth-
anol again. The samples were kept at -20°C. One micro-
gram of sample DNA was amplified over 30 cycles, each
cycle consisting of denaturation at 94°C for 1 min, primer
annealing at 55°C for 1 min, and chain elongation with 1
U of Taq polymerase (Roche) at 72°C for 2 min. PCR
amplification was carried out in a final volume of 50 μl of
10 mM Tris-hydrochloride pH 8.3 containing 0.2 mM
deoxynucleotide triphosphates (Roche), 3 mM MgCl2
(Roche), 50 mM KCl (Sigma) and 0.25 μM of each primer
(MWG, Germany). In the first cycle, the samples were
denatured at 94°C for 5 min, and in the last cycle the
extension step was increased to 7 min. The primers used
for amplification were selected from the published
sequence of BoHV-4 genome [14] (sense primer:5'-cgaat-
tctagtctaaagtcatcctc-3'; antisense primer: 5'-cgaattccatt-
ggcttcatcccaca-3'. Accession number: NC_002665). The
PCR products were electrophoresed in 1% agarose gel and
visualized after ethidium bromide staining. The amplified
2538-bp TK fragment was extracted from the agarose gel,
digested with HindIII restriction endonuclease, and ana-
lyzed on 1.5% agarose gel in 1× TAE buffer (40 mM Tris-
acetate, 1 mM EDTA) containing ethidium bromide. The
specificity of the PCR product was determined by
sequencing and compared with the GeneBank deposed
sequence, Accession number: S49773 or NC_002665.
Sequence alignment was performed with: Basic Local
Alignment Search Tool (NCBI, National Center for Bio-
technology Information, USA)
RNA extraction and RT-PCR
Total RNA from infected and uninfected cells was
extracted with TriPure reagent (Roche) and 2 μg of total
RNA were reverse transcribed using Ready-To-Go, T-
Primed First-Strand Kit (Amersham Biosciences, Milano
Italy). Three microliters of reverse transcribed RNA were
amplified over 30 cycles, each cycle consisting of denatur-
ation at 94°C for 1 min, primer annealing at 55°C for 1
min, and chain elongation with 1 U of Taq polymerase
(Boehringer-Diagnostics, Milano, Italy) at 72°C for 2
min. PCR amplification was carried out in a final volume
of 50 μl of 10 mM Tris-hydrochloride, pH 8.3, containing
0.2 mM deoxynucleotide triphosphates, 3 mM MgCl2, 50
mM KCl and 0.25 μM of each primer (sense primer: 5'-
acaaacacacagaccagtca-3'; antisense primer: 5'-gtttcacaaca-
gattgagca-3' Primers were selected from the published
sequence of BoHV-4 genome. Accession Number
NC002665) [14].
BAC-BoHV-4-U generation
For BAC cloning of the BoHV-4-U genome, a strategy
employed to BAC clone the BoHV-4-A genome was used
[15]. The intergenic region between the ORF2 and ORF3
was chosen because it was previously shown to be suitable
for the introduction of the BAC cassette, and pSP72Bo2-
loxGFP-BAClox-Bo3 was excised from pSP72Bo2-loxGFP-
BAClox-Bo3 [15] by PvuII/ClaI restriction digestion and
the gel-purified fragment was co-electroporated with 1 μg
of purified BoHV-4-U DNA in BEK cells. GFP positive
plaques were isolated and transferred onto newly pre-
pared BEK cells. After several rounds of isolation, circular
viral DNA intermediates were isolated from infected cells
by the Hirt isolation method [16] and transferred intoReproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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Escherichia coli DH10B (Promega, Milano, Italy). The
transformants were plated on agar containing 17 μg/ml
chloramphenicol. DNA was extracted from each positive
clone, restriction enzyme digested, and analyzed by elec-
trophoresis on 1% agarose gel. DNA fragments were visu-
alized with a UV transilluminator.
Cell culture electroporation and recombinant virus 
reconstitution
BEK or BEKcre cells were maintained as a monolayer with
complete medium containing 90% D-MEM, 10% FBS, 2
mM l-glutamine, 100 IU/ml penicillin and 10 μg/ml
streptomycin. Cells were sub-cultured in a fresh culture
vessel when growth reached 7090% confluence (i.e., every
35 days) and incubated at 37°C in a humidified atmos-
phere with 5% CO2. BAC-BoHV-4 plasmid DNA (5 μg) in
500  μl D-MEM without serum was electroporated
(Equibio apparatus, 270 V, 960 μF, 4-mm gap cuvettes)
into BEK or BEKcre cells from a confluent 25-cm2 flask.
Electroporated cells were returned to the flask, fed the next
day, and split 1:2 when they reached confluence 2 days
after electroporation. Cells were left to grow until CPE
appeared. Recombinant viruses were propagated by
infecting confluent monolayers of BEK or MDBK cells at a
m.o.i. of 0.5 TCID50 per cell and maintaining in MEM
with 10% FBS for 2 h. The medium was then removed and
replaced by fresh MEM containing 10% FBS. When
approximately 90% of the cell monolayer exhibited CPE
(approximately 72 h post-infection), the virus was pre-
pared by freezing and thawing cells three times and pellet-
ing virions through 30% sucrose. Virus pellets were
resuspended in ice cold D-MEM without FBS. TCID50 were
determined on MDBK cells by limiting dilution.
BAC-BoHV-4-U genome modification by recombineering
Recombineering was performed as described by Warming
et al. (2005) [17] with some modifications. Briefly, 500 μl
SW102 E. coli containing BAC-BoHV-4-U cultured over-
night at 32°C was diluted in 25 ml Luria-Bertani (LB)
(Sigma) medium with or without 12.5 μg/ml chloram-
phenicol (Sigma) selection and grown at 32°C in a 50 ml
baffled conical flask to an OD600 of 0.6. Then, 10 ml were
transferred to another baffled 50 ml conical flask and
heat-shocked at 42°C for exactly 15 min in a shaking
water bath. The remaining culture was left at 32°C as the
uninduced control. After 15 min the two samples were
briefly cooled in an ice/water bath, transferred to 15 ml
Falcon tubes and pelleted at 3000 × g for 5 min at 0°C.
The supernatant was poured off and the pellet was resus-
pended in 1 ml ice-cold ddH2O by gently swirling the
tubes in an ice/water bath. Subsequently, 9 ml ice-cold
ddH2O were added and the samples pelleted again. This
step was repeated once more, the supernatant was
removed and the pellet (50 μl each) was kept on ice until
electroporated with a gel-purified ~4.3 kb fragment (TK-
KanaGalK-TK) obtained by cutting pTK-KanaGalK-TK
with XhoI/EcoRI (Roche). An 25 μl aliquot was used for
each electroporation (Equibios apparatus, Equibios,
Milano, Italy) in a 0.1 cm cuvette (Promega) at 25 μF, 2.-
5 kV and 201 Ω. After electroporation, the bacteria were
recovered in 1 ml LB (15 ml Falcon tube) for 1 h in a 32°C
shaking water bath. For the counter selection step (see
below), the bacteria were recovered in 10 ml LB in a 50 ml
baffled conical flask and incubated for 4.5 h in a 32°C
shaking water bath.
After the recovery period, the bacteria were washed twice
in sterile 1× M9 salts (6 g/l Na2HPO4, 3 g/l KH2PO4, 1 g/l
NH4Cl and 0.5 g/l NaCl,) (Sigma) as follows: 1 ml culture
was pelleted in an eppendorf tube at 10,000 × g for 15
min and the supernatant was removed with a pipette. The
pellet was resuspended in 1 ml of 1× M9 salts, and pel-
leted again. This washing step was repeated once more.
After the second wash, the supernatant was removed and
the pellet was resuspended in 1 ml of 1× M9 salts before
plating serial dilutions (100 μl each of 1:10, 1:100 and
1:1000 dilutions) on M63 minimal medium plates (agar
15 g/l; (DIFCO, BD Biosciences, Milano, Italy), 0.2% D-
galactose (Sigma), 1 mg/l D-biotin (Sigma), 45 mg/l L-
leucine (Sigma) and 50 mg/l kanamycin (Sigma). Wash-
ing in M9 salts is necessary to remove any rich media from
the bacteria prior to selection on minimal medium plates.
Plates were incubated for 3 to 5 days at 32°C. Several
selected colonies were picked and streaked on McConkey
agar indicator plates (DIFCO, BD Biosciences) containing
50 μg/ml of kanamycin, and incubated at 32°C for 3 days
until red colonies appeared. Red colonies were grown
overnight in 5 ml of LB containing 50 μg/ml of kanamycin
and BAC-BoHV-4-U was purified and analyzed through
HindIII restriction enzyme digestion for TK-KanaGalK-TK
fragment targeted integration into the BoHV-4 TK locus.
Results
BoHV-4 isolation from the uterus of an infected animal
A cow with a history of postpartum metritis was BoHV-4
IFAT positive twice at 6-month intervals (Fig. 1A). Uterine
cells were collected from this animal and co-cultivated
with BoHV-4 permissive cell lines. Ten days after co-cul-
ture and one cell passage, a CPE typical of BoHV-4
appeared in the BEK cells (Fig. 1B). The presence of BoHV-
4 was confirmed by immuno-peroxidase staining of the
plaques with anti-BoHV-4 antibodies (Fig. 1C).
BoHV-4 isolate characterization
To confirm the specificity of the BoHV-4 isolate, single-
plaque purified virus was analyzed by RFLP-PCR of the TK
locus (Fig. 2A) and RT-PCR for the spliced form of the IE2
gene (Fig. 2B), which is a specific marker for BoHV-4
immediate early gene expression [13]. Both methods con-
firmed the specificity of the uterine isolate, which wasReproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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A) Representative microscopic (10×) IFAT images of sera from the cow which was used to isolate BoHV-4-U Figure 1
A) Representative microscopic (10×) IFAT images of sera from the cow which was used to isolate BoHV-4-U. 
The presence of anti-BoHV-4 antibodies in the first and second sample (6 months following the first) are detectable by green 
cells when observed with a FITC filter and the negative controls appears brown due to the Evans blue dye. Counterstaining 
with Evans blue dye observed with a TRITC/filter (red pictures) was used to monitor the integrity of the cell substrate. The 
merged pictures (FITC/TRITC) allow co-localization of the anti-BoHV-4 antibody staining with the cellular substrate. B) Repre-
sentative phase contrast microscopic images (10×) of BoHV-4-U cytopathic effect generating plaques. C) Representative phase 
contrast microscopic images (10×) of BoHV-4-U plaques immuno-peroxidase stained with anti-BoHV-4 antibodies.Reproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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A) Predicted location of HindIII restriction sites and respective expected restriction fragment sizes (not shown to scale) Figure 2
A) Predicted location of HindIII restriction sites and respective expected restriction fragment sizes (not shown 
to scale). Ethidium bromide stained agarose gel electrophoresis of specific amplification of BoHV-4 DNA fragment from LVR, 
DN599 reference strains and the BoHV-4-U isolate. PCR amplified 2,538-bp fragment (Uncut) and digested with HindIII 
restriction enzyme (Cut). Lanes (-) correspond to negative controls and La to 1 kb ladder molecular size marker. B) Diagram 
showing the genomic region containing the BoHV-4 IE2 gene (not to scale), where the exon II contains most of the IE2 ORF, 
except the translation initiation codon contained into the exon I. During splicing, an intron is removed and the two exons (I 
and II) are joined together to generate the IE2 ORF. The position of the primers used to amplify the region containing IE2 are 
shown by arrows. The selected primers generate an amplicon of 1400 bp from the viral IE2 genomic region, while the amplicon 
is only 386 bp in length from the spliced product of IE2 transcript, thus allowing distinction between viral genomic DNA and 
the reverse transcribed IE2 RNA. Ethidium bromide stained agarose gel electrophoresis of RT-PCR or PCR of RNA and DNA 
from LVR, DN599 reference strains and the new isolate BoHV-4-U infected cells.Reproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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called BoHV-4-U. A restriction profile comparing the
BoHV-4-U viral genome with reference strains (LVR and
Movar, kindly provided by Professor Castrucci, University
of Perugia, Pisa Italy. DN 599, ATCC-VR-631), classified
the isolate as Movar-like (data not shown), which was in
agreement with the geographical distribution of the
Movar strain in the north of Italy [18].
Cloning of BoHV-4-U as a bacterial artificial chromosome
To facilitate further characterization and manipulation of
BoHV-4-U, the genome was cloned as a bacterial artificial
chromosome. The intergenic region located between Bo2
and Bo3 ORFs (situated to the left end of the viral
genome, Fig. 3A) [14] was selected as a target site to intro-
duce the BAC cassette. Plasmid (pBo2-EGFP-BAC-Bo3),
containing homologous regions flanking the floxed BAC
cassette for cre excision and an EGFP expression cassette,
was linearized and co-transfected with BoHV-4-U purified
genome into BEK cells. Recombinant virus was isolated
from single plaques expressing EGFP and the structure of
the recombinant virus was assessed by HindIII restriction
profiling, PCR and sequencing. Circular intermediates of
the recombinant BoHV-4-U were isolated from newly
infected BEK cells and electroporated into E. coli DH 10B
to generate pBAC-BoHV-4-U (Fig. 3B). HindIII restriction
profile (Fig. 3C), Southern blotting, PCR and partial
sequencing (data not shown) confirmed the integrity of
the clone.
Clonal stability and viral reconstitution
The stability of the pBAC-BoHV-4-U clone in bacteria was
confirmed over twenty passages (Fig. 4A). Electroporation
of the pBAC-BoHV-4-U plasmid into BEK cells, allowed
infectious virus reconstitution as observed by plaques
expressing green fluorescent protein formation and CPE
spreading through the cell monolayer over time (Fig. 4B).
The BAC cassette was successfully excised from the BAC-
BoHV-4-U, as monitored by the lost of GFP expression,
when the BAC-BoHV-4-U virus was growth on BEK cells
expressing cre or the pBAC-BoHV-4-U plasmid was elec-
troporated into BEK cells expressing cre (Fig. 4C). There
were no differences in growth characteristics between
BoHV-4-U, BAC-BoHV-4-U and BoHV-4-UΔBAC (Fig.
4D).
Insertional mutagenesis into BoHV-4-U genome cloned as 
Bacterial Artificial Chromosome
The BAC recombineering system [17], modified by the
introduction of a kanamycin selection step, was used to
test the feasibility of using BoHV-4-U for mutagenesis.
The galactokinase cassette (GalK) along with a kanamycin
resistance cassette, both under the control of constitu-
tively active prokaryotic promoters, were subcloned in
pINT2 [19] to be flanked by the BoHV-4 TK gene and adja-
cent sequences. The generated targeting vector (TK-Kana-
GalK-TK) was excised out from the plasmid backbone and
used for heat-inducible homologous recombination in
SW102 E. coli containing the BAC BoHV-4 genome. Fol-
lowing positive selection in minimal medium containing
galactose and a second positive selection with medium
containing kanamycin, all the clones analyzed displayed
the correct target (Fig. 5).
Discussion and conclusion
BoHV-4 is a herpesvirus belonging to the gammaherpesvi-
rus family, genus Rhadinovirus [14]. Although BoHV-4 has
been isolated from animals with various clinical symp-
toms and from apparently healthy animals, BoHV-4 isola-
tion from animals with disease of the female genital tract
is the best documented and one of the few cases where
disease could be reproduced [20]. Wellemans et al, (1986)
reproduced metritis by infecting cows at various times
before parturition; no clinical signs were seen after pri-
mary infection but metritis was observed after parturition.
It is likely that BoHV-4 causes post-partum metritis along
with other microbes such as the bacteria E. coli and A. pyo-
genes [11]. In the present study a BoHV-4 strain (BoHV-4-
U) was isolated from the uterus of a persistently infected
cow, affected by postpartum metritis. The authenticity of
the isolate was confirmed by RFLP-PCR and sequencing
using a large 2,538 bp conserved region (TK lokus) as a
genetic marker region for the BoHV-4 genome, [21],
including the 3' end of ORF1 (homologous to the EBV
BVRF1 gene), ORF2 (homologous to the EBV BXRF1
gene), ORF3 (TK gene) and ORF4 (gH gene) 5' end. The
presence of the spliced form of the IE2 gene, a specific
marker for BoHV-4 immediate early expression [22], was
identified by RT-PCR and sequencing. The BoHV-4-U
genome was cloned as a bacterial artificial chromosome
(BAC) and the stability of the pBAC-BoHV-4-U clone was
confirmed over twenty passages. Furthermore, the growth
of the engineered virus was similar to the growth of the
wild type virus. Finally, the feasibility of using BoHV-4-U
for mutagenesis was demonstrated using the BAC recom-
bineering system.
Strain adaptation of microbes for an organ, tissue or cell
type is an important issue for the pathogenesis of disease.
Differences observed in the disease potential of BoHV-4
may constitute an adaptation of the virus to different
selection pressures that increase the frequency of the most
pathogenic genetic variants. These selection pressures
might include the endometrial environment, so to under-
stand the effects of BoHV-4 on uterine function it is
important to use a specific BoHV-4 isolated from a case of
postpartum metritis. For example, Nuget et al. (2006)
[23] found that neuro-pathogenic EHV-1 strains encode G
whereas non-pathogenic EHV-1 strains encode A in posi-
tion 2,254 of the genome corresponding to the viral DNA
polymerase (pol) ORF. The relationship between poly-Reproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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Representative flow chart of the strategy used to generate pBAC-BoHV-4-U Figure 3
Representative flow chart of the strategy used to generate pBAC-BoHV-4-U. A) Through classical homologous 
recombination in eukaryotic cells obtained by co-transfection, the floxed (loxP sites indicated by triangles) CMV-GFP BAC cas-
sette containing F1 plasmids elements (chloramphenicol resistant gene, Cam; F1 origin of replication, Ori2; partitioning protein 
genes, repE, parA, parB and parC), flanked by two homologous BoHV-4-U regions, Bo2 and Bo3, was introduced into the 
intergenic region of the BoHV-4-U genome [Numbers indicates sequence location in BoHV-4 genome based on the Zimmer-
mann's sequence [14]]. B) Diagram of the recombinant BoHV-4-U and images of a single plaque expressing GFP (Fluorescence 
and phase contrast merged on fluorescence. 10×). C) Ethidium bromide stained agarose gel of three (1, 2, 3) representative 
HindIII digested pBAC-BoHV-4-U clones.Reproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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A) Stability of the pBAC-BoHV-4-U plasmid in E. coli DH10B Figure 4
A) Stability of the pBAC-BoHV-4-U plasmid in E. coli DH10B. DH10B containing the pBAC-BoHV-4-U were passaged 
for 21 consecutive days, BAC DNA from the culture was prepared on the indicated days (3, 6, 9, 12,15, 18 and 21), HindIII 
digested and analyzed on ethidium bromide stained agarose gel. B) BEK or C) BEK expressing cre cells (BEK/cre) at 3 and 5 
days post electroporation with pBAC-BoHV-4-U, where BAC-BoHV-4-U virus is reconstituted causing CPE and spreading 
through the cellular monolayer as shown by both phase contrast and fluorescence images (in B). Whereas, due to the expres-
sion of cre and the BAC cassette containing GFP is removed from the BAC-BoHV-4-U reconstituted, CPE is appreciable in 
phase contrast images but not in fluorescence (in C). D) Replication kinetics of BoHV-4-A-U reconstituted virus in BEK/cre 
cells (the BAC cassette has been removed by cre), compared with those of the parental BAC-BoHV-4-U (virus reconstituted 
on un-expressing cre BEK cells) still containing the BAC cassette and the BoHV-4-U isolate. The data presented are the means 
± standard errors of triplicate measurements, P > 0,05 for all time points as measured by Student's t test.Reproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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(A) Kanamycin resistant cassette (Kana) adjacent to the galactokinase cassette (GalK) and flanked by BoHV-4 thymidine Kinase  gene and adjacent sequences (TK), are introduced into the TK gene of BoHV-4-U genome cloned as bacterial artificial chromo- some (BAC-BoHV-4-U) via heat inducible homologous recombination in SW 102 E. coli Figure 5
(A) Kanamycin resistant cassette (Kana) adjacent to the galactokinase cassette (GalK) and flanked by BoHV-4 
thymidine Kinase gene and adjacent sequences (TK), are introduced into the TK gene of BoHV-4-U genome 
cloned as bacterial artificial chromosome (BAC-BoHV-4-U) via heat inducible homologous recombination in 
SW 102 E. coli. Following a positive selection on (solid) minimal plates containing galactose as the only source of carbon and 
a positive selection on (liquid) medium containing Kanamycin. b) HindIII restriction enzyme analysis of 2 clones out of hun-
dreds, displaying the right targeting, where a new 2.6 kb band (indicated by arrow) corresponding to the insertion of the Kana/
GalK cassettes is present but missing in the untargeted control. Southern hybridization with a Kanamycin specific probe con-
firms the specific targeting.Reproductive Biology and Endocrinology 2009, 7:83 http://www.rbej.com/content/7/1/83
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morphism in EHV-1 pol and neuro-pathogenicity was ver-
ified by targeted mutagenesis of a single nucleotide in the
DNA genome of the virus cloned as bacterial artificial
chromosome [24]. Similarly, the uterine isolate of BoHV-
4 genome cloned as bacterial artificial chromosome could
then be modified by homologous recombination and the
virus reconstituted in eukaryotic cells following transfec-
tion to study mechanisms of pathogenicity.
The primary method for investigating the function of indi-
vidual herpesvirus genes is mutagenesis. Mutated viruses
are usually constructed by homologous recombination
following the co-transfection of viral genomic DNA and a
mutated allele on a separate DNA fragment [25]. Recom-
binant viruses are either screened or selected during sev-
eral sequential rounds of plaque purification. However, if
the mutation results in growth defects relative to wild-type
parental virus, the mutant virus may be difficult or impos-
sible to purify. Lethal mutations are often detected only
indirectly by the unsuccessful isolation of the desired
mutant virus. Such mutants can be isolated and con-
firmed as lethal only by the construction of a complemen-
tary cell line expressing the wild-type allele. To overcome
these limitations, many herpesvirus have been cloned as
an infectious bacterial artificial chromosome (BAC).
Although the genome of BoHV-4 has been sequenced
completely [14] the function of most of the gene remains
unknown. Fewer than 75 ORFs have been characterized in
BoHV-4, based on amino acids homology and genome
location. While most of the genes have no apparent
homology to known viral or cellular genes, some are
important for virus-host interaction. For example, IE2
gene, is the molecular master switch for BoHV-4 replica-
tion, and the capability of endometrial cells to transacti-
vate the IE2 promoter was previously investigated by
transient transfection with a reporter construct containing
the IE2 promoter transfected into endometrial cells [11].
Therefore the mutation of the IE2 gene in BoHV-4-U
would be of great interest, to understand its function in
the context of the interaction between a specific uterine
strain (BoHV-4-U) and the endometrial cells.
The functional analysis of BoHV-4-U genes in endome-
trial cells is a fundamental prerequisite for regulatory
region discovery. Gene trap technology [26] in combina-
tion with transposition technology, site direct mutagene-
sis and homologous recombination on BAC-BoHV-4-U
genome, will provide an important tool to carry out a
large-scale search and analysis of BoHV-4-U regulatory
regions. Targeting genes or regions of gene expression reg-
ulation and the phenotypic analysis of the BoHV-4-U
mutants, represents a powerful tool to study the direct and
indirect interactions of genes and genomic elements in a
biological context, such as in the uterus. The classification
of mutants into functional clusters will help identify
uncharacterized genes responsible for BoHV-4 strain
adaptation to the uterine microenvironment. The estab-
lished BoHV-4-U library of mutants together with differ-
ent endometrial cell types will cover a substantial amount
of biological information of intrinsic value about the
functional relationship of the targeted genes and the host
background.
In conclusion, the uterine adapted BoHV-4-U genome
cloned as a bacterial artificial chromosome provides a
tractable tool that can be used to explore the complex
interactions between BoHV-4 and the host cells of the
endometrium.
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